In a 28-year-old man with three days of hematochezia and a history of intermittent bleeding, whose colonoscopy three years ago revealed microscopic colitis and hemorrhoids, what investigations should be initiated now and should treatment be started?

Management of Recurrent Hematochezia in a Young Patient with Known Microscopic Colitis and Hemorrhoids

This patient requires outpatient colonoscopy within 2 weeks to evaluate for new pathology, and treatment should be initiated based on whether symptoms are primarily from microscopic colitis (diarrhea) or hemorrhoids (bleeding alone). 1

Investigations to Initiate

Immediate Assessment

• Calculate the Oakland score to determine if outpatient management is appropriate (score ≤8 points indicates safe discharge for outpatient investigation). 1
• Assess for anemia with complete blood count, as approximately 20% of patients with lower GI bleeding present with anemia. 2
• Review current medications specifically for NSAIDs, proton pump inhibitors, selective serotonin reuptake inhibitors, and statins, as these are strongly associated with microscopic colitis and may trigger symptoms. 1, 3

Endoscopic Evaluation

• Outpatient colonoscopy within 2 weeks is indicated because 6% of patients presenting with lower GI bleeding have underlying bowel cancer, and this patient is experiencing recurrent symptoms with a 3-year gap since last evaluation. 1
• Complete colonoscopy is superior to flexible sigmoidoscopy because proximal lesions may be missed; in one study, 9.9% of young adults with hematochezia had adenomas, with 27% of these being proximal only. 4
• Anorectal examination with proctoscopy or retroflexion during colonoscopy is mandatory to adequately assess hemorrhoids and exclude other anorectal pathology, as benign anorectal conditions account for 16.7% of lower GI bleeding diagnoses. 1
• Multiple colonic biopsies from different segments should be obtained even if mucosa appears normal, as microscopic colitis requires histologic diagnosis and may have patchy distribution. 1

Treatment Considerations

For Microscopic Colitis Symptoms

The decision to treat depends on symptom severity and quality of life impact:

• If experiencing chronic watery diarrhea with mild symptoms: Start loperamide as first-line antidiarrheal therapy. 5, 6
• If experiencing moderate-to-severe diarrhea symptoms: Budesonide is recommended for induction of clinical remission. 1, 5
• If symptoms are intermittent and minimal: Treatment may be deferred, as microscopic colitis has a variable course and is not associated with increased mortality or risk of colorectal cancer. 1

For Hemorrhoidal Bleeding

• Conservative management with fiber supplementation, adequate hydration, and avoidance of straining should be initiated if hemorrhoids are the primary source of bleeding. 1
• Topical therapies may be considered for symptomatic relief while awaiting colonoscopy.

Critical Clinical Pitfalls

Medication Review is Essential

Discontinue or substitute offending medications (NSAIDs, PPIs, SSRIs, statins) as clinically feasible, as these are strongly associated with microscopic colitis and may perpetuate symptoms. 1, 3 Recent meta-analysis confirms NSAIDs (OR 2.57) and statins (OR 2.15) significantly increase odds of microscopic colitis compared to histological controls. 3

Don't Assume Hemorrhoids are the Sole Cause

Even in young patients with known hemorrhoids, complete colonoscopy is warranted because 1.8% of patients under age 50 with hematochezia have colorectal cancer, and 9.9% have adenomas. 4 The 3-year interval since last colonoscopy and recurrent symptoms justify repeat evaluation.

Consider Coexisting Conditions

If symptoms persist despite treatment, evaluate for celiac disease and other causes of chronic diarrhea, as these may coexist with microscopic colitis. 1 Additionally, postinflammatory functional bowel disorders may contribute to residual symptoms. 1

Distinguish Between Bleeding Sources

Microscopic colitis typically causes watery, non-bloody diarrhea, not hematochezia. 5, 7 If this patient is experiencing visible blood, hemorrhoids or another source is more likely responsible for the bleeding, while microscopic colitis may be contributing to diarrheal symptoms if present. 5

Timing and Urgency

• Patients with minor self-terminating bleeding (Oakland score ≤8) can be safely managed as outpatients with colonoscopy scheduled within 2 weeks. 1
• Admission is not required unless there is major ongoing bleeding, hemodynamic instability, or other indications for hospitalization. 1
• The 2-week timeframe aligns with guidelines for patients with unexplained rectal bleeding to exclude malignancy. 1